25 May 2013
Keywords: indonesia, kalbe, remains, premier, blue, chip, over
Article | 16 January 1995
Over the past 12 months, Indonesian drugmaker Kalbe Farma's shares have
outperformed the Jakarta Stock Exchange by 32.5%, note analysts at
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 January 1995
24 May 2013
© 2013 thepharmaletter.com